Cibc World Markets Corp Acquires New Position in NeoGenomics, Inc. (NASDAQ:NEO)
Cibc World Markets Corp bought a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 11,932 shares of the medical research company’s stock, valued at approximately $197,000. Several other hedge funds and other institutional investors have […]
Cibc World Markets Corp bought a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 11,932 shares of the medical research company’s stock, valued at approximately $197,000. Several other hedge funds and other institutional investors have […]
